| 注册
首页|期刊导航|天津中医药|参附注射液对心血管疾病的临床及药理学研究进展

参附注射液对心血管疾病的临床及药理学研究进展

施洋 王玲燕 李澜 陈景瑞 樊官伟

天津中医药2016,Vol.33Issue(10):637-640,4.
天津中医药2016,Vol.33Issue(10):637-640,4.DOI:10.11656/j.issn.1672-1519.2016.10.15

参附注射液对心血管疾病的临床及药理学研究进展

Recent advances of clinical and pharmacological studies for Shenfu injection on cardiovascular disease

施洋 1王玲燕 1李澜 1陈景瑞 1樊官伟1

作者信息

  • 1. 天津中医药大学,天津市现代中药重点实验室,天津 300193
  • 折叠

摘要

Abstract

Shenfu injection is used since 1987. The injection which originated from Ji Sheng Fang has been used nearly 30 years for clinic and received satisfied results. Now it is widely applied in heart failure, ischemia-reperfusion injury, arrhythmia, shock, myocardial infarction, coronary heart disease and other cardiovascular diseases. In recent years, scholars had fully investigated on pharmacological effects of Shenfu injection. They found that it can increase coronary blood flow, protect myocardium, antiarrhythmia, antishock and improve blood rheology. It also makes other cardiac functions better as well. This paper will review that clinical application and pharmacological research status of Shenfu injection on cardiovascular diseases at present.

关键词

参附注射液/心血管疾病/临床研究/药理学机制

Key words

Shenfu injection/cardiovascular diseases/clinical research/pharmacological mechanism

分类

医药卫生

引用本文复制引用

施洋,王玲燕,李澜,陈景瑞,樊官伟..参附注射液对心血管疾病的临床及药理学研究进展[J].天津中医药,2016,33(10):637-640,4.

基金项目

国家重点基础研究发展计划(973计划)资助项目(2012CB518404)。 ()

天津中医药

OACSTPCD

1672-1519

访问量0
|
下载量0
段落导航相关论文